The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| AKERO THERAPEUTICS INC | COM | 00973Y108 | 63,063 | 2,444,311 | SH | SOLE | 2,444,311 | 0 | 0 | ||
| ALX ONCOLOGY HLDGS INC | COM | 00166B105 | 836,134 | 9,699,925 | SH | SOLE | 9,699,925 | 0 | 0 | ||
| APELLIS PHARMACEUTICALS INC | COM | 03753U106 | 28,055 | 490,471 | SH | SOLE | 490,471 | 0 | 0 | ||
| CHECKMATE PHARMACEUTICALS IN | COM | 162818108 | 53,595 | 3,673,374 | SH | SOLE | 3,673,374 | 0 | 0 | ||
| HARMONY BIOSCIENCES HLDGS IN | COM | 413197104 | 126,692 | 3,504,624 | SH | SOLE | 3,504,624 | 0 | 0 | ||
| METACRINE INC | COM | 59101E103 | 24,045 | 3,059,123 | SH | SOLE | 3,059,123 | 0 | 0 | ||
| VERONA PHARMA PLC | SPONSORED ADS | 925050106 | 1,394 | 199,075 | SH | SOLE | 199,075 | 0 | 0 | ||